Dave Stack, Pacira Biosciences CEO
Pacira looks to expand use of Exparel for pain relief following knee replacement surgery
Pacira Biosciences is hoping that the latest data surrounding its non-opioid painkiller will expand its usage post-surgery.
On Wednesday, the biotech presented topline results from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.